A

Ascendis Pharma

Biopharmaceutical company developing long-acting prodrugs

Medical Director - Clinical Development

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timePalo Alto, CA, USA$265k - $295k /yr

About the Job

Requirements

  • An M.D. degree is required.
  • At least 5 years of industry experience is required, though other relevant post-graduate clinical and/or academic experience may be considered case by case. Candidates with less experience may be considered for an Associate Medical Director position.
  • At least 3 years of experience with clinical trial design and execution is required.
  • Strong track record of scientific and clinical inquiry.
  • Strong written and oral communication skills.
  • Ability to learn quickly and follow complex directions under pressure.
  • Ability to multitask while remaining organized and attentive to detail.
  • Ability to lead directly and by example.
  • Ability to work collaboratively and reliably.
  • Ability to take initiative and solve complex problems.
  • Sound judgment in handling complex, confidential, and regulated information.

Responsibilities

  • Contribute to the formulation and implementation of the Clinical Development Plan.
  • Apply medical expertise and hands-on clinical experience to promote relevance and rigor of the development program.
  • Design clinical trials, provide overall oversight, and support site and subject retention.
  • Serve as a Medical Monitor for clinical trials, ensure study integrity, and track accumulating safety and efficacy data.
  • Provide leadership to teams of medical monitors and study teams.
  • Ensure successful completion of trial-related documents, including clinical trial protocols, investigator brochures, medical monitoring plans, site training materials, clinical study reports, health authority responses, and standard operating procedures, with cross-functional team members.
  • Analyze, evaluate, interpret, and report clinical data.
  • Anticipate and solve complex drug development problems.
  • Contribute to regulatory strategy.
  • Contribute to drafting and reviewing clinical documents, manuscripts, presentations, and regulatory submissions.
  • Maintain current knowledge of relevant science, medical information, good clinical practices, and regulatory guidance.
  • Collaborate with and serve as a clinical research resource for cross-functional colleagues in clinical operations, statistics, regulatory affairs, medical affairs, health economics outcomes research, commercial, and finance to optimize product development.
  • Contribute to corporate strategic and organizational initiatives and, when asked, represent the clinical development department.
  • Cultivate relationships with investigative sites, clinical consultants, and key opinion leaders to represent the company's interests.
  • Assist with portfolio management and commercial activities as needed.
  • Complete assigned tasks thoroughly, accurately, and on time.
  • Adhere to rigorous ethical standards.
  • Travel up to 20% domestically and internationally for scientific meetings.

Desired Qualifications

  • Completion of an ACGME-accredited residency and fellowship is strongly preferred.
  • Physician licensure in at least one state is strongly preferred.
  • Board certification is strongly preferred; endocrinology specialty is highly desired.

About the Company

Ascendis Pharma

Biopharmaceutical company developing long-acting prodrugs

Ascendis Pharma uses its TransCon technology to create long-acting prodrugs for rare endocrine diseases, with expansions into oncology and ophthalmology. The platform temporarily attaches an unmodified drug to an inert carrier and releases the active drug in a predictable, sustained way after injection, reducing how often patients must dosing. It differentiates itself through a proprietary delivery system and a track record that includes marketed therapies like SKYTROFA for pediatric growth hormone deficiency and YORVIPATH for hypoparathyroidism, along with collaborations such as a Novo Nordisk deal. The company aims to improve patient outcomes by enabling easier, less frequent dosing while expanding its pipeline across rare endocrine diseases, cancer, and eye diseases.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Gentofte Municipality, Denmark
Founded
2007

Recently Posted Jobs

Explore more opportunities at Ascendis Pharma

See more jobs